Albendazole is typically administered orally and can be given as a single dose or as part of a treatment regimen, depending on the type of infection. In MDA programs, it is often given as a preventive measure to at-risk populations, such as school-aged children. The World Health Organization (WHO) recommends periodic administration in endemic areas to reduce the worm burden and prevent reinfection.
